• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[食管T3期鳞状细胞癌。单纯手术切除的价值及预后因素分析]

[Stage T3 squamous cell carcinoma of the esophagus. Value of exclusive surgical excision and analysis of prognosis factors].

作者信息

Tabech A Z, Topart P, Vandenbroucke F, Miossec A, Lozac'h P

机构信息

Service de Chirurgie Viscérale 1, CHU de la Cavale Blanche, Brest.

出版信息

J Chir (Paris). 1997;134(9-10):362-7.

PMID:9682748
Abstract

75 patients with an epidermoid carcinoma of the esophagus were studied. They all were stage T3 with or without lymph node involvement but without distant metastasis (T3 N0 M0 or T3 N+, M0). All the patients had a curative esophagectomy according to the Ivor Lewis procedure without any adjuvant treatment. In hospital mortality was 4%. There is a 28% 5 year actuarial survival in this group of patients where 60% had lymph node involvement. None of the 13 prognostic factors showed a significant relevance with respect to survival after an univariate analysis. Meanwhile surgical treatment ensured good digestive comfort and good quality of life at home.

摘要

对75例食管鳞状细胞癌患者进行了研究。他们均为T3期,有或无淋巴结受累,但无远处转移(T3 N0 M0或T3 N+,M0)。所有患者均根据艾弗·刘易斯手术进行了根治性食管切除术,未接受任何辅助治疗。住院死亡率为4%。在这组患者中,5年精算生存率为28%,其中60%有淋巴结受累。单因素分析显示,13个预后因素中没有一个与生存有显著相关性。同时,手术治疗确保了良好的消化舒适度和在家中的良好生活质量。

相似文献

1
[Stage T3 squamous cell carcinoma of the esophagus. Value of exclusive surgical excision and analysis of prognosis factors].[食管T3期鳞状细胞癌。单纯手术切除的价值及预后因素分析]
J Chir (Paris). 1997;134(9-10):362-7.
2
[Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].[经腹-右胸两切口食管癌根治术联合二野淋巴结清扫治疗胸段下段食管鳞癌]
Ai Zheng. 2007 Mar;26(3):307-11.
3
Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.改良Ivor-Lewis食管癌切除术联合辅助放疗对胸段中段IIA期食管鳞状细胞癌局部控制的临床研究
Eur J Cardiothorac Surg. 2009 Jan;35(1):1-7. doi: 10.1016/j.ejcts.2008.09.002. Epub 2008 Oct 15.
4
[The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].[胸段中段食管鳞状细胞癌患者腹部淋巴结转移的模式及预后因素]
Zhonghua Wai Ke Za Zhi. 2008 Dec 1;46(23):1800-3.
5
Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.食管鳞状细胞癌扩大食管切除术加三野淋巴结清扫术的临床疗效
Am J Surg. 2005 Jan;189(1):98-109. doi: 10.1016/j.amjsurg.2004.10.001.
6
[Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].[Ivor-Lewis食管切除术后食管癌的复发模式——196例报告]
Ai Zheng. 2006 Jan;25(1):96-9.
7
Survival after esophageal resection for carcinoma: the importance of the histologic cell type.食管癌切除术后的生存率:组织学细胞类型的重要性。
Ann Thorac Surg. 2006 Sep;82(3):1073-7. doi: 10.1016/j.athoracsur.2006.03.012.
8
Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?改良Ivor-Lewis食管癌切除术后的辅助放疗:它能预防胸段中段食管癌的淋巴结复发吗?
Ann Thorac Surg. 2009 Jun;87(6):1697-702. doi: 10.1016/j.athoracsur.2009.03.060.
9
Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma.淋巴结受累对T2或T3期胸段食管鳞状细胞癌的影响。
Hepatogastroenterology. 2009 Jul-Aug;56(93):1039-43.
10
[Ivor Lewis surgical procedure for epidermoid cancer of the esophagus. Apropos of 264 cases].
J Chir (Paris). 1997;134(9-10):349-56.